GILD's strong HIV portfolio should maintain momentum for the company. The guidance for 2025 is impressive. We believe there ...

Gilead Sciences' Q4 earnings and sales beat estimates on higher HIV, oncology and liver disease drug sales. The stock is ...

Tiger Brokers (NASDAQ: TIGR), a leading online brokerage firm, announces that its AI-powered investment assistant, TigerGPT, has officially integrated with the DeepSeek-R1 model, becoming the first ...

bonyf Announces Plans for Dual Listing on Nasdaq and Euronext Paris with a Five-Step Strategy ...

RBC Capital Markets adjusted its outlook on Gilead Sciences (NASDAQ:GILD) stock, increasing the price target to $90 from the previous $84 while maintaining a Sector Perform rating. The adjustment ...

The Toronto Blue Jays and slugger Vladimir Guerrero Jr. did not reach an agreement on an extension before his Tuesday ...

Schwab clients may access expanded 24/5 trading by selecting the EXTO order type for eligible securities on the thinkorswim trading platforms. Visit our website to learn more about our trading ...

Q4 2024 Earnings Conference Call February 13, 2025 4:30 PM ETCorporate ParticipantsD'Andre Wright - Vice President ...

A Baylor University rundown identifies popular alumni cities. TSTC's Worksite is up and running. Natural Grocers' grand ...

US Treasury yields moved significantly higher due to a number of factors. Click here to read the full commentary.